Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 49

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 49
---
 annual report on Form 10-K for the year ended December 31, 2024, and the effectiveness of the Global Medical REIT Inc.’s internal control over financial reporting have
been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial
statements and related financial statement schedule are incorporated by reference in reliance upon the reports from such firm given their
authority as experts in accounting and auditing.

<div align='center'>S-29</div>

PROSPECTUS

<div align='center'>$750,000,000

Common Stock
Preferred Stock
Debt Securities</div>

We may offer, issue and sell from time to time,
together or separately, the securities described in this prospectus, at an aggregate public offering price that will not exceed $750,000,000.

We will provide the specific terms of any securities
we may offer in supplements to this prospectus. You should read this prospectus and any applicable prospectus supplement carefully before
you invest. This prospectus may not be used to offer and sell any securities unless accompanied by a prospectus supplement describing
the amount of and terms of the offering of those securities.

We may offer and sell these securities to or through
one or more underwriters, dealers or agents, or directly to purchasers on a continuous or delayed basis. We reserve the sole right to
accept, and together with any underwriters, dealers and agents, reserve the right to reject, in whole or in part, any proposed purchase
of securities. The names of any underwriters, dealers or agents involved in the sale of any securities, the specific manner in which they
may be offered and any applicable commissions or discounts will be set forth in the prospectus supplement covering the sales of those
securities.

We elected to be taxed as a real estate investment
trust (“REIT”) for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2016. To assist us
in complying with certain U.S. federal income tax requirements applicable to REITs, among other purposes, our charter generally limits
beneficial and constructive ownership by any person to no more than 9.8% in value or in number of shares, whichever is more restrictive,
of the outstanding shares of any class or series of our capital stock. In addition, our charter contains various other restrictions on
the ownership and transfer of our common stock. See “Description of Capital Stock — Restrictions